OpenURL Connection Search

Select item for more details and to access through your institution.

Searching for a home: phosphoinositide 3‐kinase inhibitors for chronic lymphocytic leukaemia in modern clinical practice.
Published in:
British Journal of Haematology, 2021, v. 194, n. 1, p. 9, doi. 10.1111/bjh.17472
By:
- Roeker, Lindsey E.;
- Thompson, Meghan C.;
- Mato, Anthony R.
Publication type:
Article
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.
Published in:
British Journal of Haematology, 2020, v. 188, n. 6, p. 918, doi. 10.1111/bjh.16271
By:
- Eyre, Toby A.;
- Roeker, Lindsey E.;
- Fox, Christopher P.;
- Gohill, Satyen H.;
- Walewska, Renata;
- Walter, Harriet S.;
- Forconi, Francesco;
- Broom, Angus;
- Arumainathan, Arvind;
- Brander, Danielle M.;
- Allan, John N.;
- Schuster, Stephen J.;
- Hill, Brian T.;
- Lansigan, Frederick;
- Cheson, Bruce D.;
- Lamanna, Nicole;
- Coombs, Catherine C.;
- Barr, Paul M.;
- Skarbnik, Alan P.;
- Shadman, Mazyar
Publication type:
Article
Approach to a patient with "double refractory" chronic lymphocytic leukemia: "Double, double toil and trouble" (Shakespeare).
Published in:
American Journal of Hematology, 2022, v. 97, p. S19, doi. 10.1002/ajh.26682
By:
- Aronson, Julia H.;
- Skånland, Sigrid S.;
- Roeker, Lindsey E.;
- Thompson, Meghan C.;
- Mato, Anthony R.
Publication type:
Article
Approach to a patient with "double refractory" chronic lymphocytic leukemia: "Double, double toil and trouble" (Shakespeare).
Published in:
American Journal of Hematology, 2022, v. 97, p. S19, doi. 10.1002/ajh.26682
By:
- Aronson, Julia H.;
- Skånland, Sigrid S.;
- Roeker, Lindsey E.;
- Thompson, Meghan C.;
- Mato, Anthony R.
Publication type:
Article
Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of Chemoimmunotherapy.
Published in:
Drugs, 2022, v. 82, n. 2, p. 133, doi. 10.1007/s40265-021-01657-0
By:
- Roeker, Lindsey E.;
- Thompson, Meghan;
- Mato, Anthony R.
Publication type:
Article
A History of Targeted Therapy Development and Progress in Novel–Novel Combinations for Chronic Lymphocytic Leukemia (CLL).
Published in:
Cancers, 2023, v. 15, n. 4, p. 1018, doi. 10.3390/cancers15041018
By:
- Karr, Matthew;
- Roeker, Lindsey
Publication type:
Article
Managing CLL That Has Progressed After BTK Inhibition.
Published in:
Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 6, p. 300
By:
- Roeker, Lindsey
Publication type:
Article
The potential of pirtobrutinib in multiple B-cell malignancies.
Published in:
Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221101697
By:
- Jensen, Jeffrey L.;
- Mato, Anthony R.;
- Pena, Camila;
- Roeker, Lindsey E.;
- Coombs, Catherine C.
Publication type:
Article
Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia.
Published in:
JAMA Network Open, 2019, v. 2, n. 12, p. e1916326, doi. 10.1001/jamanetworkopen.2019.16326
By:
- Roeker, Lindsey E.;
- Sarraf Yazdy, Maryam;
- Rhodes, Joanna;
- Goodfriend, Julie;
- Narkhede, Mayur;
- Carver, Joseph;
- Mato, Anthony
Publication type:
Article
The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy.
Published in:
Blood & Lymphatic Cancer: Targets & Therapy, 2020, v. 10, p. 1, doi. 10.2147/BLCTT.S262592
By:
- Ujjani, Chaitra;
- Mato, Anthony;
- Hill, Brian T;
- Allan, John N;
- Lansigan, Frederick;
- Jacobs, Ryan;
- Skarbnik, Alan;
- Tuncer, Hande;
- Pagel, John;
- Brander, Danielle;
- Cheson, Bruce;
- Barr, Paul;
- Roeker, Lindsey E;
- Pu, Jeffrey;
- Shah, Nirav N;
- Goy, Andre;
- Schuster, Stephen J;
- Lamanna, Nicole;
- Sehgal, Alison;
- Tam, Constantine S
Publication type:
Article
Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 7, p. 515, doi. 10.1016/j.clml.2023.03.010
By:
- Shadman, Mazyar;
- Manzoor, Beenish S.;
- Sail, Kavita;
- Tuncer, Hande H.;
- Allan, John N.;
- Ujjani, Chaitra;
- Emechebe, Nnadozie;
- Kamalakar, Rajesh;
- Coombs, Catherine C.;
- Leslie, Lori;
- Barr, Paul M.;
- Brown, Jennifer R.;
- Eyre, Toby A.;
- Rampotas, Alexandras;
- Schuh, Anna;
- Lamanna, Nicole;
- Skarbnik, Alan;
- Roeker, Lindsey E.;
- Bannerji, Rajat;
- Eichhorst, Barbara
Publication type:
Article
CLL-039: Pirtobrutinib (LOXO-305), a Next-Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated CLL/SLL: Results from the Phase 1/2 BRUIN Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S315, doi. 10.1016/S2152-2650(21)01746-8
By:
- Coombs, Catherine C.;
- Pagel, John M.;
- Shah, Nirav N.;
- Lamanna, Nicole;
- Lech-Maranda, Ewa;
- Eyre, Toby A.;
- Woyach, Jennifer A.;
- Wierda, William G;
- Cheah, Chan Y.;
- Roeker, Lindsey;
- Patel, Manish R.;
- Fakhri, Bita;
- Barve, Minal A.;
- Tam, Constantine S.;
- Lewis, David J.;
- Gerson, James N.;
- Alencar, Alvaro;
- Taylor, Justin;
- Abdel-Wahab, Omar;
- Ghia, Paolo
Publication type:
Article
Poster: CLL-039: Pirtobrutinib (LOXO-305), a Next-Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated CLL/SLL: Results from the Phase 1/2 BRUIN Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S221, doi. 10.1016/S2152-2650(21)01392-6
By:
- Coombs, Catherine C.;
- Pagel, John M.;
- Shah, Nirav N.;
- Lamanna, Nicole;
- Lech-Maranda, Ewa;
- Eyre, Toby A.;
- Woyach, Jennifer A.;
- Wierda, William G.;
- Cheah, Chan Y.;
- Roeker, Lindsey;
- Patel, Manish R.;
- Fakhri, Bita;
- Barve, Minal A.;
- Tam, Constantine S.;
- Lewis, David J.;
- Gerson, James N.;
- Alencar, Alvaro;
- Taylor, Justin;
- Abdel-Wahab, Omar;
- Ghia, Paolo
Publication type:
Article
Oral Abstract: CLL-039: Pirtobrutinib (LOXO-305), a Next-Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated CLL/SLL: Results from the Phase 1/2 BRUIN Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S202, doi. 10.1016/S2152-2650(21)01273-8
By:
- Coombs, Catherine C.;
- Pagel, John M.;
- Shah, Nirav N.;
- Lamanna, Nicole;
- Lech-Maranda, Ewa;
- Eyre, Toby A.;
- Woyach, Jennifer A.;
- Wierda, William G.;
- Cheah, Chan Y.;
- Roeker, Lindsey;
- Patel, Manish R.;
- Fakhri, Bita;
- Barve, Minal A.;
- Tam, Constantine S.;
- Lewis, David J.;
- Gerson, James N.;
- Alencar, Alvaro;
- Taylor, Justin;
- Abdel-Wahab, Omar;
- Ghia, Paolo
Publication type:
Article
Evidence for and Against Green Tea and Turmeric in the Management of Chronic Lymphocytic Leukemia.
Published in:
2018
By:
- Bange, Erin;
- Timlin, Colleen;
- Kabel, Charlene;
- Svoboda, Jakub;
- Roeker, Lindsey;
- Mato, Anthony R.
Publication type:
journal article
Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in previously treated CLL/SLL: updated results from the phase 1/2 BRUIN study.
Published in:
Acta Haematologica Polonica, 2022, v. 53, n. A, p. 33
By:
- Jurczak, Wojciech;
- Mato, Anthony;
- Pagel, John;
- Coombs, Catherine C.;
- Shah, Nirav N.;
- Lamanna, Nicole;
- Lech-Maranda, Ewa;
- Eyre, Toby A.;
- Munir, Talha;
- Woyach, Jennifer A.;
- Wierda, William G.;
- Cheah, Chan Y.;
- Cohen, Jonathon;
- Roeker, Lindsey;
- Patel, Manish R.;
- Fakhri, Bita;
- Barve, Minal A.;
- Tam, Constantine S.;
- Lewis, David;
- Gerson, James N.
Publication type:
Article
Cyclic Bicytopenia in a Patient with Shapiro Syndrome.
Published in:
Case Reports in Hematology, 2013, p. 1, doi. 10.1155/2013/231713
By:
- Roeker, Lindsey E.;
- Gupta, Vinay;
- Gonsalves, Wilson I.;
- Wolanskyj, Alexandra P.;
- Gangat, Naseema
Publication type:
Article
Management of CLL patients early in the COVID‐19 pandemic: An international survey of CLL experts.
Published in:
American Journal of Hematology, 2020, v. 95, n. 8, p. E199, doi. 10.1002/ajh.25851
By:
- Koffman, Brian;
- Mato, Anthony;
- Byrd, John C.;
- Danilov, Alexey;
- Hedrick, Brad;
- Ujjani, Chaitra;
- Roeker, Lindsey;
- Stephens, Deborah M.;
- Davids, Matthew S.;
- Pagel, John M.;
- Shadman, Mazyar
Publication type:
Article
Outcomes of front‐line ibrutinib treated CLL patients excluded from landmark clinical trial.
Published in:
American Journal of Hematology, 2018, v. 93, n. 11, p. 1394, doi. 10.1002/ajh.25261
By:
- Mato, Anthony R.;
- Roeker, Lindsey E.;
- Allan, John N.;
- Pagel, John M.;
- Brander, Danielle M.;
- Hill, Brian T.;
- Cheson, Bruce D.;
- Furman, Richard R.;
- Lamanna, Nicole;
- Tam, Constantine S.;
- Handunnetti, Sasanka;
- Jacobs, Ryan;
- Lansigan, Frederick;
- Bhavsar, Erica;
- Barr, Paul M.;
- Shadman, Mazyar;
- Skarbnik, Alan P.;
- Goy, Andre;
- Beach, Douglas F.;
- Svoboda, Jakub
Publication type:
Article
Imatinib-associated melanosis of the palate.
Published in:
American Journal of Hematology, 2014, v. 89, n. 5, p. 564, doi. 10.1002/ajh.23589
By:
- Roeker, Lindsey E.;
- Wolanskyj, Alexandra P.
Publication type:
Article
Pruritus in primary myelofibrosis: Clinical and laboratory correlates.
Published in:
American Journal of Hematology, 2012, v. 87, n. 2, p. 136, doi. 10.1002/ajh.22215
By:
- Vaa, Brianna E.;
- Wolanskyj, Alexandra P.;
- Roeker, Lindsey;
- Pardanani, Animesh;
- Lasho, Terra L.;
- Finke, Christy M.;
- Tefferi, Ayalew
Publication type:
Article
A real‐world study to assess the association of cardiovascular adverse events (CVAEs) with ibrutinib as first‐line (1L) treatment for patients with chronic lymphocytic leukaemia (CLL) in the United States.
Published in:
EJHaem, 2023, v. 4, n. 1, p. 135, doi. 10.1002/jha2.638
By:
- Mato, Anthony;
- Tang, Boxiong;
- Azmi, Soraya;
- Yang, Keri;
- Han, Yi;
- Zhang, Xiaowei;
- Roeker, Lindsey;
- Wallis, Nicola;
- Stern, Jennifer C.;
- Hedrick, Eric;
- Huang, Jane;
- Sharman, Jeff P.
Publication type:
Article

Found: 22